scholarly article | Q13442814 |
P356 | DOI | 10.1016/0002-8703(73)90139-7 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0002870373901397?httpAccept=text/xml |
https://api.elsevier.com/content/article/PII:0002870373901397?httpAccept=text/plain | ||
P698 | PubMed publication ID | 4728124 |
P50 | author | David J. Greenblatt | Q88911712 |
P2093 | author name string | J. Koch-Weser | |
P2860 | cites work | Propranolol-induced depression | Q28365619 |
Comprehensive Drug Surveillance | Q30241219 | ||
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST | Q33971458 | ||
Computer analysis of epidemiologic data on effect of drugs on hospital patients | Q36074990 | ||
Perspectives in adrenergic beta-receptor blockade | Q39982386 | ||
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications | Q40039750 | ||
The treatment of shock with beta adrenergic blockade | Q43528426 | ||
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications | Q44729426 | ||
Effect of Age and Sex on Human Drug Metabolism | Q50348052 | ||
The effect of propranolol on anxiety. | Q51346924 | ||
Unwanted effects of propranolol. | Q54222395 | ||
The treatment of migraine with propranolol | Q54427936 | ||
DRUG SURVEILLANCE UTILISING NURSE MONITORS An Epidemiological Approach | Q57946623 | ||
Beta adrenergic blockade in the circulatory regulation of hyperkinetic states | Q68751439 | ||
Propranolol in hypertension: a study of long-term therapy, 1964-1970 | Q70437062 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Cardiology and cardiovascular medicine | Q96320350 |
P304 | page(s) | 478-484 | |
P577 | publication date | 1973-10-01 | |
P1433 | published in | American Heart Journal | Q2227156 |
P1476 | title | Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program | |
Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program | |||
P478 | volume | 86 |
Q34515782 | A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension |
Q40085968 | Adverse effects of antianxiety drugs |
Q67275834 | Adverse effects of antiarrhythmic drugs |
Q40311396 | Adverse effects of antihypertensive drugs |
Q39874234 | Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program |
Q28330850 | Adverse reactions to practolol in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program |
Q39103748 | Alpha- and Beta-Adrenergic Receptor Blocking Agents Combined with a Diuretic in the Treatment of Essential Hypertension |
Q43944377 | An approach to the treatment of essential hypertension |
Q51868908 | Anaesthetic problems associated with the treatment of cardiovascular disease: II. beta-adrenergic antagonists |
Q72512060 | Angiodysplasia |
Q72542990 | Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease |
Q72540066 | Anxiety and depression in patient on nadolol |
Q40090423 | Beta-adrenergic blockade and the gastrointestinal system |
Q36465582 | Beta-adrenergic function in aging. Basic mechanisms and clinical implications |
Q67516362 | Beta-adrenergic receptor blockade and renal function |
Q34246704 | Beta-blocking drugs and anxiety |
Q39793128 | Blood Levels of Drugs Used in the Treatment of Cardiac Arrhythmias |
Q66922477 | Brady-Tachy Syndrome with Prolonged Retrograde Conduction due to Digitalis and Propranolol Intoxication |
Q38160762 | Clinical Pharmacology of Antihypertensive Drugs in Children |
Q72570518 | Clinical experiences in arterial hypertension in the elderly |
Q42247574 | Clinical responses to oxprenolol in the elderly |
Q42274072 | Complete atrioventricular block associated with propranolol therapy |
Q44080790 | Delta infection without increase in severity of hepatitis |
Q67007351 | Detection of drug-induced disease |
Q72430108 | Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents |
Q34110511 | Drug prescribing for the elderly. |
Q39774063 | Drug use in the elderly: a review of problems and special considerations |
Q37105405 | Drug-Induced Cardiovascular Diseases |
Q69567038 | Effect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory ST-segment monitoring |
Q67490056 | Effects of oxprenolol on the airways of normal and bronchitic subjects |
Q39105831 | Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias |
Q39155283 | Evidence for Improved Cardiac Performance after Beta-Blockade in Patients with Coronary Artery Disease |
Q35000479 | Geriatric pharmacology |
Q36999217 | High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequences |
Q83358999 | Hypertension in the elderly |
Q93857498 | Hypertension in the elderly |
Q67592437 | Intravenous atenolol in elderly patients in the early phase of acute myocardial infarction |
Q72484754 | Long-term course of arterial hypertension treated with beta-blockers. 1. Comparison with the results obtained with non-beta-blocking antihypertensive agents |
Q34063156 | Pharmacologic therapy of ventricular arrhythmias |
Q37149283 | Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes |
Q69871419 | Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance |
Q46123053 | Propranolol toxicity presenting with early repolarization, ST segment elevation, and peaked T waves on the ECG. |
Q67312007 | Propranolol-induced Urticaria: Successful Therapy with Tolamolol |
Q34248581 | Psychopharmacologic issues in the diagnosis and treatment of organic mental disorders. |
Q66942615 | Psychosis: A Probable Result of Propranolol Therapy |
Q33880949 | Relationship between polymorphisms in beta -2 adrenergic receptor gene and ischemic stroke in North Indian Population: a hospital based case control study |
Q36489562 | Required beta blocker profile in the elderly |
Q38749920 | Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis |
Q36927124 | Side effects and contraindications of beta-receptor blocking agents |
Q70336545 | Simplified antihypertensive therapy with pindolol retard |
Q36716830 | Surgical treatment of hypertrophic obstructive cardiomyopathy in the elderly |
Q72030112 | Systolic functional response of normal older and younger adult left ventricles to beta-blockade during exercise |
Q57797740 | The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population |
Q34517399 | The effect of ageing on the hepatic clearance of propranolol |
Q34448943 | The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration |
Q67314644 | The relationship of paroxysmal ventricular tachycardia complicating the acute phase and ventricular arrhythmia during the late hospital phase of myocardial infarction to long-term survival |
Q40327652 | Therapeutic drug monitoring of antiarrhythmic agents |
Q34516492 | beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation |
Search more.